MARKSANS PHARMA INC.

The article discusses the importance of enabling JavaScript for optimal app performance.

The U.S. OTC drugs market is projected to grow from USD 42.80 billion in 2024 to USD 53 billion by 2029, driven by high Rx drug costs and increased OTC approvals. Dermatology and tablets segments are expected to lead growth. Key players include Johnson & Johnson, Novartis, Bayer, Sanofi, and Pfizer.